Morgan Stanley Call 145 ABT 21.03.../ DE000MB93FX4 /
15/05/2024 18:58:25 | Chg.+0.001 | Bid22:00:36 | Ask22:00:36 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.056EUR | +1.82% | - Bid Size: - |
- Ask Size: - |
Abbott Laboratories | 145.00 USD | 21/03/2025 | Call |
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
15/03
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
14/11/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
19/10/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
02/10/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
GlobeNewswire
06/09/2023
Endexx Corporation Appoints Ahmed Itani to Director of Marketing of HYLA in The Middle East Region